Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan versus tadalafil in mechanically ventilated COPD patients with pulmonary hypertension
IRCT20190325043107N24Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in chronic obstructive pulmonary disease (COPD) and pulmonary hypertension (PH) comparing Bosentan arm with Tadalafil arm (2 arms). Primary endpoints: Pulmonary function, Pulmonary artery pressure and 2 more. Started Nov 2021; status: completed.
02
Drugs
bosentantadalafil
03
Conditions
chronic obstructive pulmonary disease (COPD)pulmonary hypertension (PH)
Beyond the preview
Go deeper on IRCT20190325043107N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N24.